Systematic review of suicidal behaviors related to methylphenidate and atomoxetine in patients with attention deficit hyperactivity disorder - Kim JH, Park S, Lee YJ.
This study investigated the relationship between suicidal behavior and the use of methylphenidate (MPH) or atomoxetine (ATX) in patients with attention deficit hyperactivity disorder (ADHD). METHODS: The Preferred Reporting Items for Sy... (Source: SafetyLit)
Source: SafetyLit - May 16, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Breaking it down: a systematic review unravelling the impact of attention deficit hyperactivity disorder and methylphenidate on childhood fractures - Garg G, Umeano L, Iftikhar S, Alhaddad SF, Paulsingh CN, Riaz MF, Khan S.
Limb fractures are a common cause of pediatric hospital admissions and surgeries, with a significant prevalence in the United Kingdom across all injury categories. Among psychiatric conditions in children, attention deficit hyperactivity disorder (ADHD) st... (Source: SafetyLit)
Source: SafetyLit - April 26, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Methylphenidate Linked to Small Increase in CV Event Risk Methylphenidate Linked to Small Increase in CV Event Risk
Methylphenidate was associated with a small increased risk for cardiovascular events in individuals taking the drug for more than 6 months in a new cohort study.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 18, 2024 Category: Psychiatry Tags: Cardiology Source Type: news

In Utero Rx Stimulant Exposure Not Tied to Later Neurodevelopmental Issues
THURSDAY, Feb. 1, 2024 --Amphetamine/dextroamphetamine and methylphenidate exposure in utero does not appear to increase the risk for childhood neurodevelopmental disorders, according to a study published online Jan. 24 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 1, 2024 Category: Pharmaceuticals Source Type: news

Is methylphenidate an effective treatment for children and adolescents with attention deficit hyperactivity disorder (ADHD) and does it cause unwanted effects?
Monday, October 23, 2023 (Source: Cochrane News and Events)
Source: Cochrane News and Events - October 23, 2023 Category: Information Technology Authors: Paolo Rosati Source Type: news

Attention deficit hyperactivity disorder, physical abuse and methylphenidate treatment in children - Man KKC, Gao L, Lau WCY, Fan M, Coghill PD, Chan EW, Chui CSL, Li X, Chan AYL, Lum PT, Luo H, Au Yeung SL, Wei PL, Wong KHTW, Tung KTS, Wong RS, Lee PTMC, Rao PN, Wing PYK, Ip P, Wong PICK.
We examined temporal associations of physical abuse risk with methylphenidate treatment in children with attention deficit hyp... (Source: SafetyLit)
Source: SafetyLit - September 11, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

There Is No Evidence That Links ADHD Meds To Substance Use Disorder
A new study says taking ADHD medicines like methylphenidate during childhood are not associated with substance use disorders in early adulthood. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 5, 2023 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news

What Are the Symptoms of Serotonin Syndrome?
Discussion Serotonin syndrome (SS) is a clinical diagnosis and problem which can be seen in patients of all ages. Classically SS presents with changing mental status, autonomic dysfunction and neuromuscular excitability. It is caused by increased serotonin levels because of therapeutically increasing the dose of a medication already being taken, adding an additional serotoninergic medication or one that potentiates serotonin, overlapping transition when changing medications, or intentional or unintentional overdose. It has become more common especially as selective serotonin reuptake inhibitors (SSRIs) have been used more ...
Source: PediatricEducation.org - May 8, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Featured Review: Methylphenidate for children and adolescents with ADHD
Monday, March 27, 2023 (Source: Cochrane News and Events)
Source: Cochrane News and Events - March 27, 2023 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic disorder: a nationwide longitudinal cohort study in South Korea - Park J, Lee DY, Kim C, Lee YH, Yang SJ, Lee S, Kim SJ, Lee J, Park RW, Shin Y.
BACKGROUND: Methylphenidate (MPH) is the most frequently prescribed medication for the treatment of attention deficit hyperactivity disorder (ADHD). However, the safety of its long-term use remain unclear. In particular, real-world evidence of long-term MP... (Source: SafetyLit)
Source: SafetyLit - October 13, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Methylphenidate Is Overprescribed to Children in France Methylphenidate Is Overprescribed to Children in France
New prescriptions for methylphenidate have been increasing in France, data show. These prescriptions sometimes are written in the absence of a diagnosis of ADHD, which is the drug ' s only indication.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 14, 2022 Category: Internal Medicine Tags: Psychiatry News Source Type: news

The effects of methylphenidate treatment on bullying perpetration and victimization in children and adolescents with attention-deficit/hyperactivity disorder - Karaosman T, Gumus YY.
OBJECTIVE: Although it is known that attention-deficit/hyperactivity disorder (ADHD) increases the risk of bullying perpetration and victimization, the data on the effect of methylphenidate (MPH) treatment, which is frequently used in the treatment of ADHD... (Source: SafetyLit)
Source: SafetyLit - March 7, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

ADHD Med May Reduce Apathy in Alzheimer's Disease ADHD Med May Reduce Apathy in Alzheimer's Disease
Methylphenidate is associated with a significantly greater reduction in apathy in patients with Alzheimer ' s disease compared with placebo -- and has a good safety profile, a new phase 3 trial suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 4, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Treatment with methylphenidate for attention deficit hyperactivity disorder (ADHD) and the risk of all-cause poisoning in children and adolescents: a self-controlled case series study - Gao L, Man KKC, Chan EW, Chui CSL, Li X, Coghill D, Hon KL, Tse ML, Lum TYS, Wong KHTW, Ip P, Wong ICK.
BACKGROUND: Children and adolescents with attention deficit hyperactivity disorder (ADHD) are at higher risk of all-cause poisoning by drugs and chemicals (intentional or accidental). Currently, there is limited data on whether medication treatment for ADH... (Source: SafetyLit)
Source: SafetyLit - July 25, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Methylin (methylphenidate HCI)
Title: Methylin (methylphenidate HCI)Category: MedicationsCreated: 7/17/2021 12:00:00 AMLast Editorial Review: 7/17/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 17, 2021 Category: Drugs & Pharmacology Source Type: news